Related Experiment Videos
Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB
Xiao-chun Bai1, Di Lu, Jie Bai
1Department of Cell Biology, The First Military Medical University, Guangzhou, PR China.
Abstract:
Signaling pathways involved in oxidative stress-induced inhibition of osteoblast differentiation are not known. We showed in this report that H(2)O(2) (0.1-0.2mM)-induced oxidative stress suppressed the osteoblastic differentiation process of primary rabbit bone marrow stromal cells (BMSC) and calvarial osteoblasts, manifested by a reduction of differentiation markers including alkaline phosphatase (ALP), type I collagen, colony-forming unit-osteoprogenitor (CFU-O) formation, and nuclear phosphorylation of Runx2. H(2)O(2) treatment stimulated phospholipase C-gamma1 (PLC-gamma1), extracellular signal-regulated kinase 1/2 (ERK1/2), and NF-kappaB signaling but inhibited p38 mitogen-activated protein kinase (MAPK) activation. In the presence of 20microM PD98059 or 50microM caffeic acid phenethyl ester (CAPE), specific inhibitor for ERKs or NF-kappaB, respectively, could significantly reverse the decrease of above-mentioned osteoblastic differentiation markers elicited by H(2)O(2) (0.1mM). Furthermore, PD98059 also suppressed H(2)O(2)-stimulated NF-kappaB signaling in this process. These data suggest that ERK and ERK-dependent NF-kappaB activation is required for oxidative stress-induced inhibition of osteoblastic differentiation in rabbit BMSC and calvarial osteoblasts.
Insights
Oxidative stress inhibits osteoblast differentiation by activating ERK and NF-kappaB signaling pathways. Blocking these pathways with inhibitors reversed the suppressive effects of hydrogen peroxide (H2O2) on bone cell differentiation.
Area of Science:
- Cell Biology
- Biochemistry
- Orthopedics
Background:
- Osteoblast differentiation is crucial for bone formation and maintenance.
- Oxidative stress is implicated in various bone diseases, but its specific effects on osteoblasts are not fully understood.
- Identifying the signaling pathways involved is key to understanding and potentially treating bone disorders.
Purpose of the Study:
- To investigate the signaling pathways mediating oxidative stress-induced inhibition of osteoblast differentiation.
- To determine the role of specific kinases and transcription factors in this process.
- To explore potential therapeutic targets for mitigating oxidative stress in bone cells.
Main Methods:
- Primary rabbit bone marrow stromal cells (BMSC) and calvarial osteoblasts were treated with hydrogen peroxide (H2O2) to induce oxidative stress.
- Osteoblast differentiation markers such as alkaline phosphatase (ALP), type I collagen, and Runx2 phosphorylation were assessed.
- Key signaling molecules including phospholipase C-gamma1 (PLC-gamma1), ERK1/2, NF-kappaB, and p38 MAPK were analyzed.
- Specific inhibitors (PD98059 for ERK, CAPE for NF-kappaB) were used to block signaling pathways.
Main Results:
- H2O2-induced oxidative stress significantly suppressed osteoblast differentiation markers and Runx2 phosphorylation.
- H2O2 treatment activated PLC-gamma1, ERK1/2, and NF-kappaB signaling while inhibiting p38 MAPK.
- Inhibition of ERK or NF-kappaB pathways partially or fully reversed the H2O2-induced suppression of osteoblast differentiation.
- PD98059 also inhibited H2O2-stimulated NF-kappaB signaling, indicating a crosstalk between these pathways.
Conclusions:
- ERK and ERK-dependent NF-kappaB activation are critical mediators of oxidative stress-induced inhibition of osteoblast differentiation in rabbit BMSC and calvarial osteoblasts.
- Targeting the ERK/NF-kappaB signaling axis may offer a therapeutic strategy to counteract bone loss associated with oxidative stress.
Related Concept Videos
Osteoclasts in Bone Remodeling
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...